Who
Erick Wayne DeVinney
Chief Innovation Officer
Company insider
Files Form 4 as: Chief Innovation Officer, Axogen.
In numbers
- Trades disclosed
- 130
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jan 2014
- Last trade
- 16 Mar 2026
- Last filed
- 18 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —6,363 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $94K2,870 at $32.84 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,575 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,363 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,575 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $171K5,221 at $32.84 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,363 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,575 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —6,363 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $94K2,870 at $32.84 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,575 at $0.00 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $171K5,221 at $32.84 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $346K11,276 at $30.65 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $346K11,276 at $30.65 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —33,780 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $341K10,702 at $31.90 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —33,780 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $341K10,702 at $31.90 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Erick Wayne DeVinney; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.